Heck M M, Gschwend J E, Retz M
Urologische Klinik und Poliklinik , Klinikum rechts der Isar, Technische Universität München, München.
Urologe A. 2010 Oct;49(10):1294-300. doi: 10.1007/s00120-010-2380-y.
This review summarizes results of neoadjuvant and adjuvant trials for locally advanced bladder cancer as well as data on systemic chemotherapy for metastatic urothelial cancer. Increasing attention has been drawn to targeted cancer therapies in the treatment of urothelial cancer in recent years. In future, molecular profiling will play a major role as a means to tailor individual therapy.
本综述总结了局部晚期膀胱癌新辅助和辅助试验的结果,以及转移性尿路上皮癌全身化疗的数据。近年来,靶向癌症治疗在尿路上皮癌治疗中受到越来越多的关注。未来,分子谱分析将作为一种定制个体化治疗的手段发挥重要作用。